{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T16:17:36Z","timestamp":1648916256169},"reference-count":27,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2017.7684","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T11:44:10Z","timestamp":1513856650000},"source":"Crossref","is-referenced-by-count":0,"title":["A novel approach to glioma therapy using an oncolytic adenovirus with two specific promoters"],"prefix":"10.3892","author":[{"given":"Feng","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaya","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jixiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhizhong","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, The Laboratory of Molecular Biology, Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"key20200714002445_b1-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.canlet.2015.06.002","article-title":"MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo","volume":"365","author":"Ulasov","year":"2015","journal-title":"Cancer Lett"},{"key":"key20200714002445_b2-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N Engl J Med"},{"key":"key20200714002445_b3-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S1470-2045(13)70274-2","article-title":"Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial","volume":"14","author":"Westphal","year":"2013","journal-title":"Lancet Oncol"},{"key":"key20200714002445_b4-ol-0-0-7684","unstructured":"HollandECGlioblastoma multiforme: The terminatorProc Natl Acad Sci USA9762426244200010.1073\/pnas.97.12.624210841526"},{"key":"key20200714002445_b5-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/sj.cgt.7700547","article-title":"Selectively replicating viral vectors","volume":"9","author":"Nemunaitis","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"key20200714002445_b6-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.1158\/0008-5472.CAN-04-0499","article-title":"Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma","volume":"64","author":"Geoerger","year":"2004","journal-title":"Cancer Res"},{"key":"key20200714002445_b7-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.4161\/cbt.29842","article-title":"Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells","volume":"15","author":"Wei","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"key20200714002445_b8-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/77283","article-title":"Replicative adenoviruses for cancer therapy","volume":"18","author":"Alemany","year":"2000","journal-title":"Nat Biotechnol"},{"key":"key20200714002445_b9-ol-0-0-7684","first-page":"6165","article-title":"Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency","volume":"62","author":"van Beusechem","year":"2002","journal-title":"Cancer Res"},{"key":"key20200714002445_b10-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/cgt.2008.67","article-title":"E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer","volume":"16","author":"Fukuda","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"key20200714002445_b11-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00535-012-0623-y","article-title":"Conditionally replicative adenovirus-based mda-7\/IL-24 expression enhances sensitivity of colon cancer cells to 5-fluorouracil and doxorubicin","volume":"48","author":"Xu","year":"2013","journal-title":"J Gastroenterol"},{"key":"key20200714002445_b12-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1158\/1078-0432.CCR-0349-03","article-title":"Use of replicating oncolytic adenoviruses in combination therapy for cancer","volume":"10","author":"Chu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20200714002445_b13-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nrc948","article-title":"Oncolytic viruses","volume":"2","author":"Chiocca","year":"2002","journal-title":"Nature Rev Cancer"},{"key":"key20200714002445_b14-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/jnci\/95.9.652","article-title":"Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway","volume":"95","author":"Fueyo","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"key20200714002445_b15-ol-0-0-7684","first-page":"764","article-title":"Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts","volume":"62","author":"Geoerger","year":"2002","journal-title":"Cancer Res"},{"key":"key20200714002445_b16-ol-0-0-7684","first-page":"5736","article-title":"Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy","volume":"62","author":"Lamfers","year":"2002","journal-title":"Cancer Res"},{"key":"key20200714002445_b17-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1566524053586536","article-title":"Telomerase-dependent gene therapy","volume":"5","author":"Wirth","year":"2005","journal-title":"Curr Mol Med"},{"key":"key20200714002445_b18-ol-0-0-7684","first-page":"3181","article-title":"A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer","volume":"63","author":"Wirth","year":"2003","journal-title":"Cancer Res"},{"key":"key20200714002445_b19-ol-0-0-7684","first-page":"1","article-title":"Conditionally replicating adenoviruses for cancer treatment","author":"Alemany","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"key20200714002445_b20-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1038\/sj.onc.1206372","article-title":"Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression","volume":"22","author":"Wilhelmsson","year":"2003","journal-title":"Oncogene"},{"key":"key20200714002445_b21-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/glia.20179","article-title":"Downregulation of GFAP, TSP-1 and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus","volume":"51","author":"Lee","year":"2005","journal-title":"Glia"},{"key":"key20200714002445_b22-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1517\/14712598.2013.845662","article-title":"Advances in adenovirus-mediated p53 cancer gene therapy","volume":"13","author":"Tazawa","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"key20200714002445_b23-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy","volume":"6","author":"Heise","year":"2000","journal-title":"Nat Med"},{"key":"key20200714002445_b24-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/glia.440150309","article-title":"Gene amplification in human gliomas","volume":"15","author":"Collins","year":"1995","journal-title":"Glia"},{"key":"key20200714002445_b25-ol-0-0-7684","first-page":"143","article-title":"The expression of p53, mgmt and egfr in brain glioma and clinical significance","volume":"29","author":"Lin","year":"2015","journal-title":"J Biol Regul Homeost Agents"},{"key":"key20200714002445_b26-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.neulet.2012.11.047","article-title":"p53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2","volume":"534","author":"Chen","year":"2013","journal-title":"Neurosci Lett"},{"key":"key20200714002445_b27-ol-0-0-7684","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00432-009-0701-6","article-title":"Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma","volume":"136","author":"Yang","year":"2010","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:54:53Z","timestamp":1594688093000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.7684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3892\/ol.2017.7684","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]}}}